Mouse Anti-Human CR1 Monoclonal Antibody (CTJS-788)(Cat#: CTA-238)

Name: Mouse Anti-Human CR1 Monoclonal Antibody (CTJS-788)
SKU: CTA-238
Rating: 5 (1 reviews)

This product is an unconjugated anti-Human CR1 Monoclonal antibody (CTJS-788) generated from the Mouse. The antibody can be used for WB; IHC; FC; IP; ELISA.

INQUIRY

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP

Summary Related Products & Services

Specifications

Clonality	Monoclonal
Clone	CTJS-788
Host Animal	Mouse
Isotype	IgG1
Immunogen	Human CD35
Species Reactivity	Human
Applications	WB; IHC; FC; IP; ELISA
Application Notes	The optimal working dilutions should be determined by the end user.
Specificity	This antibody reacts with Human CR1.
Purity	≥95% as determined by SDS-PAGE
Format	Liquid
Size	50 µL
Storage	Store at 4°C. Do not freeze.
Type	Primary Antibody

Target

Target Name	CR1
Alternative Names	Complement C3b/C4b Receptor 1 (Knops Blood Group); C3b/C4b Receptor; CD35 Antigen; Knops Blood Group Antigen; Complement Receptor 1; C3-Binding Protein; Complement Receptor Type 1; KN; C3BR; C4BR; CD35; Cr1; C3DR; CD21; Cr-1; Cr-2
Gene ID	1378
UniProt ID	P17927

Information

Introduction

Complement receptor 1 (CR1) also known as CD35, cluster of differentiation 35, is a protein that in humans is encoded by the CR1 gene. CR1 can act as a negative regulator of the complement cascade, mediate immune adherence and phagocytosis and inhibit both the classic and alternative pathways. Complement receptor 2 (CR2), also known as CD21, cluster of differentiation 21, is a protein that in humans is encoded by the CR2 gene. CR2 is involved in the complement system. It binds to iC3b (inactive derivative of C3b), C3dg, or C3d. B cells have CR2 receptors on their surfaces, allowing the complement system to play a role in B-cell activation and maturation.

For Research Use Only. Not for Diagnostic or Therapeutic Applications.